<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Experimental evidence has shown that the amount of 5-HIAA in the CSF reflects the metabolism of <z:chebi fb="19" ids="28790">serotonin</z:chebi> in the brain if this metabolite is eliminated from the brain and flows into the CSF at a constant rate </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the concentration of 5-HIAA in the lumbar CSF in several <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> to elucidate the alteration in abnormalities of <z:chebi fb="19" ids="28790">serotonin</z:chebi> metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>The concentration of 5-HIAA in the CSF was measured in 94 patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, 30 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 25 with <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer type, 28 with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> and 6 with hypoxic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> were classified into 24 with a solitary cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> and 70 with multiple cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> were subdivided into 12 with various <z:e sem="disease" ids="C0852553" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychiatric symptoms</z:e> including <z:e sem="disease" ids="C0011570" disease_type="Mental or Behavioral Dysfunction" abbrv="">depressive state</z:e>, <z:hpo ids='HP_0000738'>hallucination</z:hpo> and/or <z:hpo ids='HP_0100543'>intellectual impairment</z:hpo> and 16 without <z:e sem="disease" ids="C0852553" disease_type="Mental or Behavioral Dysfunction" abbrv="">psychiatric symptoms</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with hypoxic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> consisted of 5 with <z:e sem="disease" ids="C0854369" disease_type="Mental or Behavioral Dysfunction" abbrv="">apallic syndrome</z:e> and one patient with Lance-Adams syndrome </plain></SENT>
<SENT sid="6" pm="."><plain>The concentration of 5-HIAA in solitary cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath>, multiple cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> did not exhibit a significant difference from that in control cases (54.6 +/- 23.1 ng/ml) </plain></SENT>
<SENT sid="7" pm="."><plain>But patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer type (34.5 +/- 10.9, p less than 0.001) showed a significantly lower concentration </plain></SENT>
<SENT sid="8" pm="."><plain>This fact seems to reflect the pathological finding that the number of large neurons is decreased and <z:hpo ids='HP_0002185'>neurofibrillary tangles</z:hpo> are increased in the nucleus raphe dorsalis of patients with Alzheimer type <z:hpo ids='HP_0000726'>dementia</z:hpo>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>